{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:06:44Z","timestamp":1792811204772,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orthop\u00e4die"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00132-022-04301-1","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T13:02:51Z","timestamp":1662555771000},"page":"792-799","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Osteonekrosen\u00a0\u2013 gravierende Therapiefolge bei akuter lymphoblastischer Leuk\u00e4mie","Osteonecrosis\u2014severe side effect of treatment for acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"51","author":[{"given":"Michaela","family":"Kuhlen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Kunstreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"G\u00f6kbuget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Escherich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"issue":"27","key":"4301_CR1","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","volume":"33","author":"CH Pui","year":"2015","unstructured":"Pui\u00a0CH et\u00a0al (2015) Childhood acute lymphoblastic leukemia: progress through collaboration. J\u00a0Clin Oncol 33(27):2938\u20132948","journal-title":"J Clin Oncol"},{"issue":"12","key":"4301_CR2","doi-asserted-by":"publisher","first-page":"5515","DOI":"10.1182\/blood-2007-10-117150","volume":"111","author":"R Mody","year":"2008","unstructured":"Mody\u00a0R et al (2008) Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a\u00a0report from the Childhood Cancer Survivor Study. Blood 111(12):5515\u20135523","journal-title":"Blood"},{"key":"4301_CR3","unstructured":"\u3008dirjahrbuch2015d.pdf\u3009."},{"issue":"2","key":"4301_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000494809","volume":"91","author":"S Mostoufi-Moab","year":"2019","unstructured":"Mostoufi-Moab\u00a0S, Ward\u00a0LM (2019) Skeletal morbidity in children and adolescents during and following cancer therapy. Horm Res Paediatr 91(2):137\u2013151","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"4301_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12016-010-8217-z","volume":"41","author":"C Powell","year":"2011","unstructured":"Powell\u00a0C, Chang\u00a0C, Gershwin\u00a0ME (2011) Current concepts on the pathogenesis and natural history of steroid-induced osteonecrosis. Clin Rev Allergy Immunol 41(1):102\u2013113","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"4301_CR6","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jbspin.2006.01.025","volume":"73","author":"P Lafforgue","year":"2006","unstructured":"Lafforgue\u00a0P (2006) Pathophysiology and natural history of avascular necrosis of bone. Joint Bone Spine 73(5):500\u2013507","journal-title":"Joint Bone Spine"},{"issue":"2 Suppl","key":"4301_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pbc.21405","volume":"50","author":"RD Barr","year":"2008","unstructured":"Barr\u00a0RD, Sala\u00a0A (2008) Osteonecrosis in children and adolescents with cancer. Pediatr Blood Cancer 50(2 Suppl):483\u2013485 (discussion 486)","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"4301_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ajpath.2013.03.004","volume":"183","author":"LJ Janke","year":"2013","unstructured":"Janke\u00a0LJ et al (2013) Primary epiphyseal arteriopathy in a\u00a0mouse model of steroid-induced osteonecrosis. Am J Pathol 183(1):19\u201325","journal-title":"Am J Pathol"},{"issue":"11","key":"4301_CR9","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3324\/haematol.2016.147595","volume":"101","author":"M Kunstreich","year":"2016","unstructured":"Kunstreich\u00a0M et\u00a0al (2016) Osteonecrosis in children with acute lymphoblastic leukemia. Haematologica 101(11):1295\u20131305","journal-title":"Haematologica"},{"issue":"18","key":"4301_CR10","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1200\/JCO.2000.18.18.3262","volume":"18","author":"LA Mattano Jr","year":"2000","unstructured":"Mattano\u00a0LA Jr et\u00a0al (2000) Osteonecrosis as a\u00a0complication of treating acute lymphoblastic leukemia in children: a\u00a0report from the Children\u2019s Cancer Group. J\u00a0Clin Oncol 18(18):3262\u20133272","journal-title":"J Clin Oncol"},{"issue":"12","key":"4301_CR11","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1200\/JCO.2001.19.12.3066","volume":"19","author":"AJ Strauss","year":"2001","unstructured":"Strauss\u00a0AJ et\u00a0al (2001) Bony morbidity in children treated for acute lymphoblastic leukemia. J\u00a0Clin Oncol 19(12):3066\u20133072","journal-title":"J Clin Oncol"},{"issue":"6","key":"4301_CR12","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/sj.leu.2402139","volume":"15","author":"RC Ribeiro","year":"2001","unstructured":"Ribeiro\u00a0RC et al (2001) Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma. Leukemia 15(6):891\u2013897","journal-title":"Leukemia"},{"issue":"12","key":"4301_CR13","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1200\/JCO.2006.06.2539","volume":"25","author":"RA Niinimaki","year":"2007","unstructured":"Niinimaki\u00a0RA et\u00a0al (2007) High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia. J\u00a0Clin Oncol 25(12):1498\u20131504","journal-title":"J Clin Oncol"},{"issue":"7","key":"4301_CR14","first-page":"747","volume":"88","author":"M Arico","year":"2003","unstructured":"Arico\u00a0M et\u00a0al (2003) Osteonecrosis: an emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 88(7):747\u2013753","journal-title":"Haematologica"},{"issue":"3","key":"4301_CR15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/pbc.20244","volume":"44","author":"B Burger","year":"2005","unstructured":"Burger\u00a0B et al (2005) Osteonecrosis: a\u00a0treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)\u2014experiences from trial ALL-BFM 95. Pediatr Blood Cancer 44(3):220\u2013225","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"4301_CR16","doi-asserted-by":"publisher","first-page":"e544","DOI":"10.1097\/HS9.0000000000000544","volume":"5","author":"M Kuhlen","year":"2021","unstructured":"Kuhlen\u00a0M, Kunstreich\u00a0M, Gokbuget\u00a0N (2021) Osteonecrosis in adults with acute lymphoblastic leukemia: an unmet clinical need. Hemasphere 5(4):e544","journal-title":"Hemasphere"},{"issue":"10","key":"4301_CR17","doi-asserted-by":"publisher","first-page":"e27300","DOI":"10.1002\/pbc.27300","volume":"65","author":"SS Mogensen","year":"2018","unstructured":"Mogensen\u00a0SS et\u00a0al (2018) Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia. Pediatr Blood Cancer 65(10):e27300","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"4301_CR18","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S1470-2045(12)70274-7","volume":"13","author":"LA Mattano Jr","year":"2012","unstructured":"Mattano\u00a0LA Jr et al (2012) Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial. Lancet Oncol 13(9):906\u2013915","journal-title":"Lancet Oncol"},{"issue":"2","key":"4301_CR19","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/sj.leu.2405032","volume":"22","author":"B Patel","year":"2008","unstructured":"Patel\u00a0B et\u00a0al (2008) High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a\u00a0UKALL XII analysis. Leukemia 22(2):308\u2013312","journal-title":"Leukemia"},{"issue":"Supplement 1","key":"4301_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1182\/blood-2020-137488","volume":"136","author":"YK Valtis","year":"2020","unstructured":"Valtis\u00a0YK et\u00a0al (2020) Orthopedic toxicity among adolescents and young adults treated on DFCI ALL consortium trials. Blood 136(Supplement 1):31\u201332","journal-title":"Blood"},{"issue":"8","key":"4301_CR21","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1182\/blood-2010-10-311969","volume":"117","author":"JD Kawedia","year":"2011","unstructured":"Kawedia\u00a0JD et\u00a0al (2011) Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood 117(8):2340\u20132347 (quiz 2556)","journal-title":"Blood"},{"issue":"19","key":"4301_CR22","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1200\/JCO.2004.11.020","volume":"22","author":"MV Relling","year":"2004","unstructured":"Relling\u00a0MV et\u00a0al (2004) Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J\u00a0Clin Oncol 22(19):3930\u20133936","journal-title":"J Clin Oncol"},{"issue":"5","key":"4301_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/01.mph.0000163215.37147.13","volume":"27","author":"H Lackner","year":"2005","unstructured":"Lackner\u00a0H et al (2005) Aseptic osteonecrosis in children and adolescents treated for hemato-oncologic diseases: a\u00a013-year longitudinal observational study. J\u00a0Pediatr Hematol Oncol 27(5):259\u2013263","journal-title":"J Pediatr Hematol Oncol"},{"issue":"31","key":"4301_CR24","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1200\/JCO.2011.37.3217","volume":"29","author":"ML te Winkel","year":"2011","unstructured":"te Winkel\u00a0ML et al (2011) Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. J\u00a0Clin Oncol 29(31):4143\u20134150","journal-title":"J Clin Oncol"},{"issue":"5","key":"4301_CR25","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/cam4.645","volume":"5","author":"B Padhye","year":"2016","unstructured":"Padhye\u00a0B et\u00a0al (2016) Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL). Cancer Med 5(5):960\u2013967","journal-title":"Cancer Med"},{"issue":"4","key":"4301_CR26","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1111\/bjh.16589","volume":"189","author":"H Inaba","year":"2020","unstructured":"Inaba\u00a0H et\u00a0al (2020) Incidence of hip and knee osteonecrosis and their associations with bone mineral density in children with acute lymphoblastic leukaemia. Br J Haematol 189(4):e177\u2013e181","journal-title":"Br J Haematol"},{"issue":"4","key":"4301_CR27","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3324\/haematol.2020.257550","volume":"106","author":"JE van Atteveld","year":"2021","unstructured":"van Atteveld\u00a0JE et al (2021) Effect of post-consolidation regimen on symptomatic osteonecrosis in three DCOG acute lymphoblastic leukemia protocols. Haematologica 106(4):1198\u20131201","journal-title":"Haematologica"},{"issue":"10","key":"4301_CR28","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.3324\/haematol.12956","volume":"93","author":"ML te Winkel","year":"2008","unstructured":"te Winkel\u00a0ML et al (2008) Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia. Haematologica 93(10):1570\u20131574","journal-title":"Haematologica"},{"issue":"7","key":"4301_CR29","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3324\/haematol.2012.081265","volume":"98","author":"P Girard","year":"2013","unstructured":"Girard\u00a0P et\u00a0al (2013) Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood. Haematologica 98(7):1089\u20131097","journal-title":"Haematologica"},{"issue":"9","key":"4301_CR30","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.bbmt.2010.03.008","volume":"16","author":"S McAvoy","year":"2010","unstructured":"McAvoy\u00a0S et\u00a0al (2010) Corticosteroid dose as a\u00a0risk factor for avascular necrosis of the bone after hematopoietic cell transplantation. Biol Blood Marrow Transplant 16(9):1231\u20131236","journal-title":"Biol Blood Marrow Transplant"},{"issue":"17","key":"4301_CR31","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1182\/blood-2015-09-670729","volume":"127","author":"A M\u00f6ricke","year":"2016","unstructured":"M\u00f6ricke\u00a0A et al (2016) Dexamethasone vs. prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. Blood 127(17):2101\u20132112","journal-title":"Blood"},{"issue":"18","key":"4301_CR32","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1200\/JCO.2007.14.9088","volume":"26","author":"NS Kadan-Lottick","year":"2008","unstructured":"Kadan-Lottick\u00a0NS et al (2008) Osteonecrosis in adult survivors of childhood cancer: a\u00a0report from the childhood cancer survivor study. J\u00a0Clin Oncol 26(18):3038\u20133045","journal-title":"J Clin Oncol"},{"issue":"7","key":"4301_CR33","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3324\/haematol.2014.103507","volume":"99","author":"C Domenech","year":"2014","unstructured":"Domenech\u00a0C et\u00a0al (2014) Dexamethasone (6\u202fmg\/m2\/day) and prednisolone (60\u202fmg\/m2\/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial. Haematologica 99(7):1220\u20131227","journal-title":"Haematologica"},{"issue":"6","key":"4301_CR34","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1365-2141.2005.05509.x","volume":"129","author":"CD Mitchell","year":"2005","unstructured":"Mitchell\u00a0CD et\u00a0al (2005) Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial. Br J Haematol 129(6):734\u2013745","journal-title":"Br J Haematol"},{"issue":"1","key":"4301_CR35","doi-asserted-by":"publisher","first-page":"e28040","DOI":"10.1002\/pbc.28040","volume":"67","author":"ER Finch","year":"2020","unstructured":"Finch\u00a0ER et\u00a0al (2020) Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 67(1):e28040","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"4301_CR36","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1200\/JCO.2007.13.8404","volume":"26","author":"L Yang","year":"2008","unstructured":"Yang\u00a0L et\u00a0al (2008) Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia. J\u00a0Clin Oncol 26(12):1932\u20131939","journal-title":"J Clin Oncol"},{"issue":"3","key":"4301_CR37","doi-asserted-by":"publisher","first-page":"e0151433","DOI":"10.1371\/journal.pone.0151433","volume":"11","author":"C Liu","year":"2016","unstructured":"Liu\u00a0C et al (2016) Asparaginase potentiates glucocorticoid-induced osteonecrosis in a\u00a0mouse model. PLoS One 11(3):e151433","journal-title":"PLoS One"},{"issue":"5","key":"4301_CR38","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.3324\/haematol.2016.160507","volume":"102","author":"SS Mogensen","year":"2017","unstructured":"Mogensen\u00a0SS et\u00a0al (2017) Hyperlipidemia is a\u00a0risk factor for osteonecrosis in children and young adults with acute lymphoblastic leukemia. Haematologica 102(5):e175\u2013e178","journal-title":"Haematologica"},{"issue":"5","key":"4301_CR39","doi-asserted-by":"publisher","first-page":"e0216328","DOI":"10.1371\/journal.pone.0216328","volume":"14","author":"SE Karol","year":"2019","unstructured":"Karol\u00a0SE et\u00a0al (2019) Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical models. PLoS One 14(5):e216328","journal-title":"PLoS One"},{"issue":"12","key":"4301_CR40","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1182\/blood.2019000006","volume":"134","author":"LJ Janke","year":"2019","unstructured":"Janke\u00a0LJ et\u00a0al (2019) Hypertension is a\u00a0modifiable risk factor for osteonecrosis in acute lymphoblastic leukemia. Blood 134(12):983\u2013986","journal-title":"Blood"},{"issue":"6","key":"4301_CR41","doi-asserted-by":"publisher","first-page":"e27669","DOI":"10.1002\/pbc.27669","volume":"66","author":"ER Finch","year":"2019","unstructured":"Finch\u00a0ER et al (2019) Bloodstream infections exacerbate incidence and severity of symptomatic glucocorticoid-induced osteonecrosis. Pediatr Blood Cancer 66(6):e27669","journal-title":"Pediatr Blood Cancer"},{"issue":"18","key":"4301_CR42","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1002\/cncr.24474","volume":"115","author":"S Campbell","year":"2009","unstructured":"Campbell\u00a0S et al (2009) Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation. Cancer 115(18):4127\u20134135","journal-title":"Cancer"},{"issue":"1","key":"4301_CR43","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/bjh.15511","volume":"183","author":"M Kuhlen","year":"2018","unstructured":"Kuhlen\u00a0M et al (2018) Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high-risk or relapsed ALL\u2014results of the ALL-SCT 2003 trial. Br J Haematol 183(1):104\u2013109","journal-title":"Br J Haematol"},{"issue":"4","key":"4301_CR44","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/sj.bmt.1704360","volume":"33","author":"SC Kaste","year":"2004","unstructured":"Kaste\u00a0SC et\u00a0al (2004) Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant 33(4):435\u2013441","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"4301_CR45","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1038\/s41409-020-0882-9","volume":"55","author":"S Kaste","year":"2020","unstructured":"Kaste\u00a0S et al (2020) Pre- and post-magnetic resonance imaging of hips and knees for detecting osteonecrosis in children and adolescents undergoing hematopoietic cell transplantation. Bone Marrow Transplant 55(9):1837\u20131839","journal-title":"Bone Marrow Transplant"},{"issue":"15","key":"4301_CR46","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1182\/blood-2015-05-643601","volume":"126","author":"SE Karol","year":"2015","unstructured":"Karol\u00a0SE et al (2015) Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia. Blood 126(15):1770\u20131776","journal-title":"Blood"},{"issue":"5","key":"4301_CR47","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1182\/blood-2015-10-673848","volume":"127","author":"SE Karol","year":"2016","unstructured":"Karol\u00a0SE et\u00a0al (2016) Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia. Blood 127(5):558\u2013564","journal-title":"Blood"},{"issue":"6","key":"4301_CR48","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1016\/S1470-2045(16)30035-3","volume":"17","author":"K Schmiegelow","year":"2016","unstructured":"Schmiegelow\u00a0K et\u00a0al (2016) Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a\u00a0Delphi consensus. Lancet Oncol 17(6):e231\u2013e239","journal-title":"Lancet Oncol"},{"issue":"12","key":"4301_CR49","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.crad.2015.08.011","volume":"70","author":"T Niinimaki","year":"2015","unstructured":"Niinimaki\u00a0T et\u00a0al (2015) The classification of osteonecrosis in patients with cancer: validation of a\u00a0new radiological classification system. Clin Radiol 70(12):1439\u20131444","journal-title":"Clin Radiol"},{"issue":"8","key":"4301_CR50","doi-asserted-by":"publisher","first-page":"e28336","DOI":"10.1002\/pbc.28336","volume":"67","author":"H Inaba","year":"2020","unstructured":"Inaba\u00a0H et al (2020) Whole-joint magnetic resonance imaging to assess osteonecrosis in pediatric patients with acute lymphoblastic lymphoma. Pediatr Blood Cancer 67(8):e28336","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"4301_CR51","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3324\/haematol.2013.095562","volume":"99","author":"ML Te Winkel","year":"2014","unstructured":"Te Winkel\u00a0ML et\u00a0al (2014) Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia. Haematologica 99(3):430\u2013436","journal-title":"Haematologica"},{"issue":"14","key":"4301_CR52","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1182\/bloodadvances.2017007286","volume":"1","author":"M Kuhlen","year":"2017","unstructured":"Kuhlen\u00a0M et\u00a0al (2017) Osteonecrosis in children and adolescents with acute lymphoblastic leukemia: a\u00a0therapeutic challenge. Blood Adv 1(14):981\u2013994","journal-title":"Blood Adv"},{"issue":"Suppl 3","key":"4301_CR53","first-page":"O-021","volume":"64","author":"LA Mattano","year":"2017","unstructured":"Mattano\u00a0LA et al (2017) Osteonecrosis (ON) is associated with improved event free survival (EFS) in high-risk acute lymphoblastic leukemia (HR-ALL): results of Children\u2019s Oncology Group (COG) study AALL0232. Pediatr Blood Cancer 64(Suppl 3):O-21","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"4301_CR54","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.3324\/haematol.2020.252767","volume":"106","author":"ER Finch","year":"2021","unstructured":"Finch\u00a0ER et\u00a0al (2021) Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone treated mice. Haematologica 106(8):2095\u20132101","journal-title":"Haematologica"},{"issue":"10","key":"4301_CR55","doi-asserted-by":"publisher","first-page":"e29183","DOI":"10.1002\/pbc.29183","volume":"68","author":"LJ Janke","year":"2021","unstructured":"Janke\u00a0LJ et\u00a0al (2021) Effects of zoledronic acid on osteonecrosis and acute lymphoblastic leukemia treatment efficacy in preclinical models. Pediatr Blood Cancer 68(10):e29183","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"4301_CR56","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1080\/01635581.2020.1803934","volume":"73","author":"RD Laumann","year":"2021","unstructured":"Laumann\u00a0RD et\u00a0al (2021) Effect of fish oil supplementation on hyperlipidemia during childhood acute lymphoblastic leukemia treatment\u2014a pilot study. Nutr Cancer 73(9):1816\u20131820","journal-title":"Nutr Cancer"},{"issue":"11","key":"4301_CR57","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1097\/MPH.0b013e31818ab29d","volume":"30","author":"RA Niinimaki","year":"2008","unstructured":"Niinimaki\u00a0RA et\u00a0al (2008) Osteonecrosis in children treated for lymphoma or solid tumors. J\u00a0Pediatr Hematol Oncol 30(11):798\u2013802","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"4301_CR58","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1200\/JCO.2014.57.5480","volume":"33","author":"SC Kaste","year":"2015","unstructured":"Kaste\u00a0SC et\u00a0al (2015) Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids. J\u00a0Clin Oncol 33(6):610\u2013615","journal-title":"J Clin Oncol"},{"issue":"10","key":"4301_CR59","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1080\/10428194.2017.1280605","volume":"58","author":"K Krull","year":"2017","unstructured":"Krull\u00a0K et\u00a0al (2017) Osteonecrosis develops independently from radiological leukemic infiltration of bone in adolescents with acute lymphoblastic leukemia\u2014first findings of the OPAL trial. Leuk Lymphoma 58(10):2363\u20132369","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"4301_CR60","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/10428194.2018.1466292","volume":"60","author":"K Krull","year":"2019","unstructured":"Krull\u00a0K et\u00a0al (2019) Osteonecrosis in children with acute lymphoblastic leukemia at initial diagnosis and prior to any chemotherapy. Leuk Lymphoma 60(1):78\u201384","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"4301_CR61","doi-asserted-by":"publisher","first-page":"e26624","DOI":"10.1002\/pbc.26624","volume":"64","author":"SS Mogensen","year":"2017","unstructured":"Mogensen\u00a0SS et\u00a0al (2017) Early presentation of osteonecrosis in acute lymphoblastic leukemia: two children from the Nordic and Baltic cohort. Pediatr Blood Cancer 64(11):e26624","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"4301_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4055\/cios.2016.8.1.1","volume":"8","author":"P Hernigou","year":"2016","unstructured":"Hernigou\u00a0P et al (2016) Stem cell therapy for the treatment of hip osteonecrosis: a 30-year review of progress. Clin Orthop Surg 8(1):1\u20138","journal-title":"Clin Orthop Surg"},{"issue":"1","key":"4301_CR63","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13287-018-1030-y","volume":"9","author":"JS Kang","year":"2018","unstructured":"Kang\u00a0JS et\u00a0al (2018) Clinical efficiency of bone marrow mesenchymal stem cell implantation for osteonecrosis of the femoral head: a\u00a0matched pair control study with simple core decompression. Stem Cell Res Ther 9(1):274","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"4301_CR64","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1200\/JCO.2012.43.2070","volume":"31","author":"LM Vrooman","year":"2013","unstructured":"Vrooman\u00a0LM et al (2013) Postinduction dexamethasone and individualized dosing of Escherichia Coli L\u2011asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a\u00a0randomized study\u2014Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. J\u00a0Clin Oncol 31(9):1202\u20131210","journal-title":"J Clin Oncol"},{"issue":"2","key":"4301_CR65","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/ejh.12562","volume":"96","author":"N Toft","year":"2016","unstructured":"Toft\u00a0N et al (2016) Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia. Eur J Haematol 96(2):160\u2013169","journal-title":"Eur J Haematol"}],"container-title":["Die Orthop\u00e4die"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00132-022-04301-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00132-022-04301-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00132-022-04301-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T11:02:44Z","timestamp":1664449364000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00132-022-04301-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["4301"],"URL":"https:\/\/doi.org\/10.1007\/s00132-022-04301-1","relation":{},"ISSN":["2731-7145","2731-7153"],"issn-type":[{"value":"2731-7145","type":"print"},{"value":"2731-7153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"assertion":[{"value":"9 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Kuhlen, M.\u00a0Kunstreich, N.\u00a0G\u00f6kbuget und G.\u00a0Escherich geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autorinnen durchgef\u00fchrten Studien an Menschen oder Tieren. Die OPAL-Studie wurde durch die Ethikkommission der Medizinischen Fakult\u00e4t der Heinrich-Heine-Universit\u00e4t D\u00fcsseldorf (Nr.\u00a03707) und durch die zust\u00e4ndige Ethikkommission der Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen (Nr.\u00a020-140) positiv begutachtet.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}